Physician profile
Heather Freeman
NPI 1700347374
$2,141.69
in general payments reported to CMS, 2019-2025
19 companies · $77.09 in 2025
The $77.09 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,388 · 2022: $315 · 2023: $228 · 2024: $133 · 2025: $77.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $659.14 | 2021-2024 | Airsupra |
| Abbvie INC. | $296.75 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $231.82 | 2021 | |
| Novo Nordisk INC | $176.47 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.05 | 2021-2022 | |
| Glaxosmithkline, LLC. | $125.00 | 2022 | |
| Alkermes, INC. | $115.95 | 2023 | Vivitrol |
| Biohaven Pharmaceuticals, INC. | $114.10 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.07 | 2021-2023 | Trintellix |
| Regeneron Healthcare Solutions, INC. | $33.37 | 2025 | Dupixent |
| Lilly USA, LLC | $28.87 | 2023 | Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.99 | 2021-2022 | |
| Daiichi Sankyo INC. | $24.64 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.18 | 2023 | |
| Janssen Pharmaceuticals, INC | $21.43 | 2023 | Spravato |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $16.98 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.28 | 2021 | |
| Merck Sharp & Dohme LLC | $14.27 | 2021 | |
| Amarin Pharma, INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.